Next Article in Journal
6,6'-(1E,1'E)-((1R,2R)-1,2-Diphenylethane-1,2-diyl)bis(azan-1-yl-1-ylidene)bis(methan-1-yl-1-ylidene)bis(2-tert-butyl-4-((trimethylsilyl)ethynyl)phenol)
Previous Article in Journal
Benzyl 3-deoxy-3-(3,4,5-trimethoxybenzylamino)-β-L-xylopyranoside
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-(4-Methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile

1
Chemistry of Pesticides Department, National Research Centre, Dokki, Cairo 12622, Egypt
2
Solid State Physics Department, National Research Centre, Dokki, Cairo 12622, Egypt
*
Author to whom correspondence should be addressed.
Molbank 2013, 2013(1), M794; https://doi.org/10.3390/M794
Submission received: 19 December 2012 / Accepted: 18 February 2013 / Published: 27 February 2013

Abstract

:
2-(4-Methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile (4) was synthesized via nucleophilic substitution reaction of 1-methylpiperazine with 2-bromo analogue 3. The latter was obtained through bromination (Br2/AcOH) of 2-[3-oxo-1-phenyl-3-(thiophen-2-yl)propyl]malononitrile (2).

Graphical Abstract

Introduction

Pyridine-3-carbonitrile derivatives represent an important class of heterocyclic compounds characterized by promising biological properties. Recent publications describing pharmacological properties of pyridine-3-carbonitrile-containing analogues such as vasodilation activities are considered a driving force behind the present investigation [1]. Moreover, bioactivity and applications as pharmacological active agents and agricultural materials of pyridinecarbonitriles also prompted the present study [2,3]. Additionally, 4-aminopyridine-3-carbonitriles were reported as PKCθ inhibitors [4,5,6]. PKCθ, a novel isoform of protein kinase C (PKC), is crucial for the activation and survival of T cells [7]. Proof-of-concept studies with mice where the PKCθ gene was deleted or ‘knocked out’ validated that the inhibition of this kinase could have therapeutic utility in diseases such as multiple sclerosis [8] and arthritis [9]. 2-Alkoxypyridine-3-carbonitrile derivatives were reported to be active antimicrobial agents against Gram-positive, Gram-negative and acid fast bacteria and yeast [10]. Also, pyridine-3-carbonitriles with amino acid functions were reported to exhibit considerable antimicrobial properties [11]. 2-Amino-3-cyanopyridine derivatives were proved to have antitubercular activity against Mycobaterium tuberculosis H37 RV ATCC 27294, in BACTEC 12 B medium using the ALAMAR radiometric system comparing with the standard drug rifampin [12]. 4-Aryl-6-(4-pyridyl)-2-oxo/ thioxo-1,2-dihydropyridine-3-carbonitriles and 2-amino-4-aryl-6-(4-pyridyl)-pyridine-3-carbonitriles were proved to exert cardiotonic activity comparable to that of milrinone using a spontanously beating atria model from reserpine-treated guinea pigs [13]. Pyridine-3-carbonitrile analogues were also reported as fluorescent materials useful as security markers for treatment of paper [14,15,16]. From all the above reports and in continuation with our previous work directing towards construction of various pyridine-3-carbonitrile containing-compounds [17,18,19], it is intended in the present work to investigate synthesis of 2-(4-methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile.

Results and Discussion

Reaction of 3-phenyl-1-(thiophen-2-yl)-2-propen-1-one (1) with malononitrile in absolute ethanol in the presence of morpholine as a basic catalyst afforded 2-[3-oxo-1-phenyl-3-(thiophen-2-yl)propyl]-malononitrile (2) in good yield (90%). The isolated compound is similar to the product previously described [20,21] (Scheme 1). Single crystal X-ray studies of 2 provide conclusive support for its structure (Figure 1 and Figure 2). Single crystal X-ray studies of 2 show that the atomic coordinates along with their esd's and equivalent isotropic thermal parameters for non-hydrogen atoms are those which are mentioned in Table 1. Selected intramolecular bond lengths and angles are listed in Table 2.
Compound 2 crystallizes in a monoclinic unit cell and belongs to the space group P21/c and has 4 molecules per each unit cell. The thienyl ring of compound 2 is nearly planer, with maximum and minimum deviation for C(17) = −0.011(4) Å and C(19) = 0.007(5) Å from the least square plane passing through the atoms S(1)/C(14)/C(17)/C(19)/C(20). The average values of the bond lengths and angles of the thienyl ring agree with that of identical rings in similar compounds [22,23]. The dihedral angle between the least square plane passing through the thienyl ring and that through the phenyl moiety is equal to 96.0(4)° which indicates that the thienyl ring is nearly perpendicular to the phenyl ring, while the dihedral angle between the least square plane passing through the phenyl ring and the plane containing the two cyano groups is equal to 63.2(3)°. The methine carbon C(6) is a four coordinated in an asymmetric tetrahedral configuration forming angles in the range [105.5(2)°–114.2(2)°], i.e., C(6) exists in asymmetric sp3 hyperdization. The two cyano groups characterized by shortened triple bond C(9)-N(4) = 1.131(3) Å, C(11)-N(12) = 1.139(3) Å. Moreover the values of the bond angles C(6)-C(9)-N(4), C(6)-C(11)-N(12) are 178.9(3)° and 177.1(3)°, respectively confirming the sp hybridization, consistent with other similar structures [24]. The dihedral angle between the least square plane through the butanedicarbonitrile moiety [O(2), C(3), N(4), C(6), C(8), C(9), C(10), C(11), N(12)] and that through the phenyl group [C(5), C(7), C(12), C(13), C(15), C(18)] is equal to 93.4(4)°, meaning thereby, that both the moieties are held almost perpendicular to each other.
The packing diagram of the compound (Figure 2) highlights the intermolecular contacts through the hydrogen bonding. The important function of these intermolecular bonds is to stabilize the molecules in the crystallographic sites of their space group. The most important intermolecular contacts are listed in Table 3. For example, carbon atom C(6) is hydrogen bonded to the nitrogen atom N(4) of the nitrile group of the neighbouring molecule with symmetry code x, 0.5−y, 0.5+z. Also Figure 2 reveals that the molecules are arranged in a layer manner and the direction of these molecules in different layers is opposite to each other.
Bromination of 2 (Br2/AcOH) afforded 2-bromo-4-phenyl-6-(thiophen-2-yl)-pyridene-3-carbonitrile (3) [20]. The latter, upon reaction with 1-methylpiperazine in tetrahydrofuran, underwent aromatic nucleophiic substitution giving 2-(4-methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile (4) in good (80%) yield. The IR spectrum of 4 exhibits a strong nitrile stretching vibration band at ν = 2203 cm−1. 1H-NMR spectrum reveals the methyl group of the piperazinyl moiety as a singlet at δ = 2.41 ppm, while, the piperazinyl methylene protons appear as triplets at δ = 2.63 and 3.83 ppm. The 13C-NMR spectrum of 4 exhibits the pyridinyl C-3 and C-5 at δ = 91.89 and 110.24 ppm, respectively. The piperazinyl carbons appear at δ = 48.66 and 55.00 ppm, while the nitrile carbon appears at δ = 118.09 ppm. The mass spectrum (EI) of 4 exhibits the parent ion peak with a considerable relative intensity value.

Experimental

Melting points were recorded on a Stuart SMP3 melting point apparatus. IR spectra (KBr) was recorded on a Shimadzu 8400S FT-IR spectrophotometer. NMR spectra were recorded on a JEOL AS 500 (1H: 500 MHz, 13C: 125 MHz) spectrometer. MS spectra was recorded on a Shimadzu QP-2010 plus (EI, 70 eV) spectrometer. The starting compounds 1 [25], 2 and 3 [20,21] were prepared according to the previously reported procedures.

Synthesis of 2-(4-methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile (4)

A solution of 3 (1.7 g, 5 mmol) and 1-methylpiperazine (1.5 mL, 10 mmol) in tetrahydrofuran (30 mL) was refluxed for 5 h. The solid separated while refluxing was collected and identified as the corresponding 1-methylpiperazine hydrobromide (soluble in water). The clear reaction mixture was evaporated till dryness, methanol (5 mL) was added, the separated solid was collected, washed with water and crystallized from methanol to give 4 as straw-yellow needles, m.p. 144–146 °C, yield (1.3 g, 80%). IR: νmax/cm−1 2923, 2845, 2795 (CH aliphatic), 2203 (C≡N), 1569, 1539 (C=N, C=C). 1H-NMR (CDCl3): δ 2.41 (s, 3H, NCH3), 2.63 (t, 4H, 2 piperazinyl CH2, J = 4.6 Hz), 3.83 (t, 4H, 2 piperazinyl CH2, J = 4.6 Hz),7.12 (d, 1H, thienyl H-3, J = 5.35 Hz), 7.14 (s, 1H, pyridinyl H-5), 7.46 (d, 1H, thienyl H-4, J = 5.35 Hz), 7.49–7.52 (m, 3H, Ar H's), 7.56–7.58 (m, 2H, Ar H's), 7.65 (d, 1H, thienyl H-5, J = 5.30 Hz). 13C-NMR (CDCl3): δ 46.18 (NCH3), 48.66 (piperazinyl NCH2), 55.00 (piperazinyl NCH2), 91.89 (pyridinyl C-3), 110.24 (pyridinyl C-5), 118.09 (C≡N), 126.69, 128.41, 128.65, 128.90, 129.73, 129.82, 137.28, 144.24, 153.20, 157.36, 162.25 (arom. C). MS: m/z (%) 360 (M, 16), 362 [(M+2), 4]. Anal. Calcd. for C21H20N4S (360.48): C, 69.97; H, 5.59; N, 15.54. Found: C, 69.72; H, 5.48; N, 15.33.

Single Crystal X-Ray Crystallographic Data of 2

A colorless needle single crystal recrystallized from ethanol of dimensions 0.09 × 0.07 × 0.13 mm was selected and mounted on a thin glass fiber. X-ray diffraction data were collected at room temperature (T = 298 K) on Enraf Nonius Kappa CCD single crystal diffractometer with graphite monochromatic MoKα (λ = 0.71073 Å) radiation; the crystal to detector distance was 35 mm. Crystals were indexed from the first ten frames using the DENZO package and positional data were refined along with diffractometer constants to give unit cell parameters suitable for integration and scaling (DENZO, Scalepack) [26]. With φ-ω scan mode, 6291 measured reflections, 3985 independent reflections out of them 1324 reflections with I ≥ 3σ(I) were used for structure analysis. The crystal structure was solved by direct method using SIR92 program [27], which revealed the positions of all non-hydrogen atoms and refined by the full matrix least squares based on F2 using maXus package [28]. The anisotropic displacement parameters of all non-hydrogen atoms were refined, then the hydrogen atoms were introduced as a riding model with C–H = 0.96Å and refined isotropically. The maximum and the minimum heights in the final difference Fourier map were found to be, 0.64 e/Å3 and −0.68 e/Å3. The Molecular graphics were prepared using ORTEP program [29]. Chemical formula C16H12N2OS, Mr = 280.349, monoclinic, crystallizes in space group P21/c , Cell lengths “a = 13.4825(6), b = 10.8934(4), c = 10.1309(4) Å”, Cell angles “α = 90.00, β = 101.2682(13), γ = 90.00°”, V = 1459.25(10) Å3, Z = 4, Dc = 1.276 g/m3, θ values 2.910–27.485°, absorption coefficient μ (Mo-Kα) = 0.22 mm−1, F(000) = 584. Convergence for 181 variable parameters by least-squares refinement on F2 with w = 1/[σ2(Fo2) + 0.10000 Fo2]. The final agreement factors were R = 0.044 and wR = 0.073 with a goodness-of-fit of 1.376. Full crystallographic details, excluding structure factors have been deposited at Cambridge Crystallographic Data Centre (CCDC) as supplementary publication number CCDC 873576 which can be obtained free of charge (www.ccdc.cam.ac.uk/data request/cif).

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

References

  1. Barsoum, F.F. Synthesis and vasodilation activity of some novel bis(3-pyridinecarbonitrile) derivatives. Eur. J. Med. Chem. 2010, 45, 5176–5182. [Google Scholar] [CrossRef] [PubMed]
  2. Pierrat, P.; Gros, P.C.; Fort, Y. Solid phase synthesis of pyridine-based derivatives from a 2-chloro-5-bromopyridine scaffold. J. Comb. Chem. 2005, 7, 879–886. [Google Scholar] [CrossRef] [PubMed]
  3. Jose, S.P.; Mohan, S. Vibrational spectra and normal co-ordinate analysis of 2-aminopyridine and 2-amino picoline. Spectrochim. Acta A 2006, 64, 240–245. [Google Scholar] [CrossRef] [PubMed]
  4. Tumey, L.N.; Bhagirath, N.; Brennan, A.; Brooijmans, N.; Lee, J.; Yang, X.; Boschelli, D.H. 5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCθ: Optimization of enzymatic and functional activity. Bioorg. Med. Chem. 2009, 17, 7933–7948. [Google Scholar] [CrossRef] [PubMed]
  5. Shim, J.; Eid, C.; Lee, J.; Liu, E.; Chaudhary, D.; Boschelli, D.H. Synthesis and PKCθ inhibitory activity of a series of 5-vinyl phenyl sulfonamide-3-pyridinecarbonitriles. Bioorg. Med. Chem. Lett. 2009, 19, 6575–6577. [Google Scholar] [CrossRef] [PubMed]
  6. Niu, C.; Boschelli, D.H.; Tumey, L.N.; Bhagirath, N.; Subrath, J.; Shim, J.; Wang, Y.; Wu, B.; Eid, C.; Lee, J.; et al. First generation 5-vinyl-3-pyridinecarbonitrile PKCθ inhibitors. Bioorg. Med. Chem. Lett. 2009, 19, 5829–5832. [Google Scholar] [CrossRef] [PubMed]
  7. Marsland, B.J.; Kopf, M. Cell fate and function: PKC-theta and beyond. Trends Immunol. 2008, 29, 179–185. [Google Scholar] [CrossRef] [PubMed]
  8. Tan, S.-L.; Zhao, J.; Bi, C.; Chen, X.Y.C.; Hepburn, D.L.; Wang, J.; Sedgwick, J.D.; Chintalacharuvu, S.R.; Na, S. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase Cθ-deficient mice. J. Immunol. 2006, 176, 2872–2879. [Google Scholar] [CrossRef] [PubMed]
  9. Healy, A.M.; Izmailova, E.; Fitzgerald, M.; Walker, R.; Hattersley, M.; Silva, M.; Siebert, E.; Terkelsen, J.; Picarella, D.; Pickard, M.D.; et al. PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis. J. Immunol. 2006, 177, 1886–1893. [Google Scholar] [CrossRef] [PubMed]
  10. Barsoum, F.F.; Hussein, M.M. New 3-pyridinecarbonitrile derivatives and their antimicrobial properties. Boll. Chim. Farm. 2002, 141, 181–187. [Google Scholar] [PubMed]
  11. Girgis, A.S.; Kalmouch, A.; Hosni, H.M. Synthesis of novel 3-pyridinecarbonitriles with amino acids function and their fluorescence properties. Amino Acid 2004, 26, 139–146. [Google Scholar] [CrossRef] [PubMed]
  12. Vyas, D.H.; Tala, S.D.; Akbari, J.D.; Dhaduk, M.F.; Joshi, K.A.; Joshi, H.S. Synthesis and antimicrobial activity of some new cyanopyridine and cyanopyranes towards Mycobacterium tuberculosis and other microoganisms. Ind. J. Chem. 2009, 48B, 833–839. [Google Scholar]
  13. Adnan, A.B.; Azza, M.B. Novel milrinone analogous of pyridine-3-carbonitrile derivatives as promising cardiotonic agents. Eur. J. Med. Chem. 2005, 40, 1405–1413. [Google Scholar]
  14. Missori, M.; de Spirito, M.; Ferrari, L.; Selci, S.; Gnoli, A.; Bertani, F.R.; Girgis, A.S.; El-Saied, H.; Basta, A.H. Novel fluorescent security marker. Part I: Morphological and optical properties of 2-amino-6-ethoxy-4-[4-(4-morpholinyl)phenyl]-3,5-pyridinedicarbonitrile nanoparticles. J. Nanopart. Res. 2012, 14, 649–660. [Google Scholar] [CrossRef]
  15. Basta, A.H.; Girgis, A.S.; El-Saied, H.; Mohamed, M.A. Synthesis of fluorescence active pyridinedicarbonitriles and studying their application in functional paper. Mater. Lett. 2011, 65, 1713–1718. [Google Scholar] [CrossRef]
  16. Basta, A.H.; Girgis, A.S.; El-Saied, H. Fluorescence behavior of new 3-pyridinecarbonitrile containing compounds and their application in security paper. Dyes Pigm. 2002, 54, 1–10. [Google Scholar] [CrossRef]
  17. Mishriky, N.; Asaad, F.M.; Ibrahim, Y.A.; Girgis, A.S. New pyridinecarbonitriles from fluoro arylpropenones. Recl. Trav. Chim. Pays-Bas 1994, 113, 35–39. [Google Scholar] [CrossRef]
  18. Mishriky, N.; Asaad, F.M.; Ibrahim, Y.A.; Girgis, A.S. Synthetic approaches towards 5H-indeno[1,2-b]pyridines. J. Chem. Res. (S) 1997, 316–317. [Google Scholar] [CrossRef]
  19. Mishriky, N.; Ibrahim, Y.A.; Girgis, A.S.; Fawzy, N.G. Synthetic approaches towards benzo[h]quinoline-3-carbonitriles. Pharmazie 2000, 55, 269–272. [Google Scholar] [PubMed]
  20. Sharanin, Y.A.; Promonenkov, V.K.; Shestopalov, A.M. Nitrile cyclization reactions. V. 2-Aryl-3-(2-thienoyl)-1,1-dicyanopropanes and derivatives of pyridines made from them. Zh. Org. Khim. 1982, 18, 630–640. [Google Scholar] [CrossRef]
  21. Greiner-Bechert, L.; Otto, H.-H. 1,4-Pentandien-3-ones, XXXII: Reaction of 2-acetylthiophene and 2-acetylfuran with malononitrile and aldehydes, and synthesis and properties of phenylene-bis[(thienyl/furyl)nicotinonitrile] derivatives. Arch. Pharm. (Weinheim) 1991, 324, 563–572. [Google Scholar] [CrossRef]
  22. Hanton, R.L.; Moratti, C.S.; Shi Z. Simpson, J. 4,5-Dihydrocyclopenta[b]thiophen-6-one. Acta Cryst. E 2012, 68, o371–o372. [Google Scholar] [CrossRef] [PubMed]
  23. Al-Youbi, O.A.; Asiri, A.M.; Faidallah, H.M.; Ng, S.W.; Tiekink, R.T. 3-Amino-1-(thiophen-2-yl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile. Acta Cryst. E 2012, 68, o1027–o1028. [Google Scholar] [CrossRef] [PubMed]
  24. Dinnebier, R.E.; Moustafa, A.M. Powder study of propanthioamide dervative C8H6N2S2. Cryst. Res. Technol. 2009, 44, 346–350. [Google Scholar] [CrossRef]
  25. Miller, R.E.; Nord, F.F. Studies on the chemistry of heterocyclics. XVII. Thiophene polyene acids, aldehydes, and ketones. J. Org. Chem. 1951, 16, 1720–1730. [Google Scholar] [CrossRef]
  26. Otwinowski, Z.; Minor, W. Processing of X-Ray Diffraction Data Collected in Oscillation Mode. In Methods in Enzymology; Macromolecular crystallography, Part A; Carter, C.W., Jr., Sweet, R.M., Eds.; Academic Press: New York, NY, USA, 1997; Volume 276, pp. 307–326. [Google Scholar]
  27. Altomare, A.; Burla, M.C.; Camalli, 307 M.; Cascarano, G.L.; Giacovazzo, C.; Guagliardi, A.; Moliterni, A.G.G.; Spagna, R. SIR97: A new tool for crystal structure determination and refinement. J. Appl. Cryst. 1999, 32, 115–119. [Google Scholar] [CrossRef]
  28. Mackay, S.; Gilmore, C.J.; Edwards, C.; Stewart, N.; Shankland, K. maXus Computer Program for the Solution and Refinement of Crystal Structures; Bruker Nonius, The Netherlands, MacScience, Japan and The University of Glasgow, 1999. [Google Scholar]
  29. Johnson, C.K. ORTEP--II. A Fortran Thermal-Ellipsoid Plot Program; Report ORNL-5138; Oak Ridge National Laboratory: Oak Ridge, TN, USA, 1976. [Google Scholar]
Scheme 1. Synthetic route towards the targeted 2-(4-methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile (4).
Scheme 1. Synthetic route towards the targeted 2-(4-methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile (4).
Molbank 2013 m794 sch001
Figure 1. ORTEP projection of single crystal X-ray diffraction of 2.
Figure 1. ORTEP projection of single crystal X-ray diffraction of 2.
Molbank 2013 m794 g001
Figure 2. Packing preview of 2, view along b-axis.
Figure 2. Packing preview of 2, view along b-axis.
Molbank 2013 m794 g002
Table 1. Fractional atomic coordinates and equivalent isotropic thermal parameters (Å2) of 2, involving non-hydrogen atoms.
Table 1. Fractional atomic coordinates and equivalent isotropic thermal parameters (Å2) of 2, involving non-hydrogen atoms.
EntryXYzUeqOcc
S10.52589(8)0.32501(11)0.36628(12)0.0970(7)1.00
O20.69418(18)0.1481(2)0.3989(2)0.0734(15)1.00
C30.8541(2)0.1106(3)0.2723(3)0.0462(18)1.00
N40.9703(2)0.1684(3)−0.0066(3)0.082(2)1.00
C50.8211(3)−0.1158(4)0.2735(3)0.064(2)1.00
C60.9616(2)0.1392(3)0.2462(3)0.0486(17)1.00
C70.8107(2)−0.0058(3)0.2039(3)0.0495(18)1.00
C80.7870(2)0.2243(3)0.2392(3)0.0523(18)1.00
C90.9662(2)0.1547(3)0.1028(4)0.0549(18)1.00
C100.6988(2)0.2233(3)0.3113(3)0.0497(19)1.00
C111.0333(3)0.0438(3)0.3056(3)0.056(2)1.00
N121.0872(2)−0.0301(3)0.3566(3)0.082(2)1.00
C130.7604(3)−0.0079(4)0.0702(3)0.067(2)1.00
C140.6229(2)0.3184(3)0.2777(3)0.055(2)1.00
C150.7835(3)−0.2240(4)0.2129(5)0.084(3)1.00
C160.7222(3)−0.1158(6)0.0096(4)0.093(3)1.00
C170.6139(3)0.4093(4)0.1841(4)0.078(3)1.00
C180.7343(3)−0.2245(5)0.0807(6)0.095(3)1.00
C190.5267(4)0.4814(4)0.1824(4)0.105(3)1.00
C200.4737(3)0.4462(5)0.2756(5)0.107(3)1.00
Table 2. Selected intramolecular geometrical parameters [bond lengths (Å); bond angles (°)] of 2.
Table 2. Selected intramolecular geometrical parameters [bond lengths (Å); bond angles (°)] of 2.
Geometrical parametersBond lengths (Å); Bond angles (°)
S(1)-C(14)1.726(3)
S(1)-C(20)1.682(4)
O(2)-C(10)1.219(3)
C(3)-C(6)1.556(3)
C(3)-C(7)1.506(3)
C(3)-C(8)1.532(3)
N(4)-C(9)1.131(3)
C(5)-C(7)1.383(3)
C(5)-C(15)1.379(4)
C(6)-C(9)1.475(4)
C(6)-C(11)1.466(4)
C(7)-C(13)1.392(3)
C(8)-C(10)1.512(3)
C(10)-C(14)1.449(3)
C(11)-N(12)1.139(3)
C(13)-C(16)1.379(4)
C(14)-C(17)1.360(4)
C(15)-C(18)1.373(5)
C(16)-C(18)1.380(5)
C(17)-C(19)1.411(4)
C(19)-C(20)1.346(5)
C(3)-C(6)-C(9)114.2(2)
C(9)-C(6)-C(11)109.6(2)
C(3)-C(6)-C(11)110.5(2)
C(14)-S(1)-C(20)91.6(2)
N(4)-C(9)-C(6)178.9(3)
C(6)-C(11)-N(12)177.1(3)
Table 3. Hydrogen bonding geometry of 2.
Table 3. Hydrogen bonding geometry of 2.
D-H….AD-H (Å)H…A (Å)D….A (Å)D-H….A °
C6-H6-N40960(2)2.431(2)3.251(3)143.19(20)
C8-H8A-N120.960(3)2.658(2)3.409(4)135.39(20)
C17-H17-O20.960(3)2.547(2)3.336(3)139.58(24)
x, 0.5−y, 0.5+z; 2−x, 0.5+y, 0.5−z; X, 0.5−y, 0.5+z.

Share and Cite

MDPI and ACS Style

Mishriky, N.; Moustafa, A.M. 2-(4-Methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile. Molbank 2013, 2013, M794. https://doi.org/10.3390/M794

AMA Style

Mishriky N, Moustafa AM. 2-(4-Methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile. Molbank. 2013; 2013(1):M794. https://doi.org/10.3390/M794

Chicago/Turabian Style

Mishriky, Nawal, and Aisha M. Moustafa. 2013. "2-(4-Methylpiperazin-1-yl)-4-phenyl-6-(thiophen-2-yl)-pyridine-3-carbonitrile" Molbank 2013, no. 1: M794. https://doi.org/10.3390/M794

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop